Genoa Pharmaceuticals and McMaster University Collaborate in IPF Resea
- ICU
- 17/01/2013
The biotechnology company Genoa Pharmaceuticals has entered a collaboration with Dr. Martin Kolb and researchers at McMaster Universi
READ MOREThe biotechnology company Genoa Pharmaceuticals has entered a collaboration with Dr. Martin Kolb and researchers at McMaster Universi
READ MOREIn response to the announcement by the American Cancer Society, Lung Cancer Alliance (LCA) President & CEO Laurie Fenton Ambrose said on...
READ MORETreating ICU patients with severe traumatic brain injury (TBI) using guidelines-based management that relies on monitoring intracranial...
READ MOREIsis Pharmaceuticals, Inc. announced on 13 December that the US Food and Drug Administration (FDA) has granted ISIS-TTR Rx fast track design
READ MOREOutbreaks of infectious diseases, such as swine flu (H1N1) threaten global health and should be considered by funding agencies and humanitarian organiz
READ MOREInnovative Blood Test for the Prediction of Major Cardiovascular Events Expected to Launch in the First Half of 2013 BG Medicine, Inc., a di
READ MORESevere acute kidney injuries are becoming more common in the United States, rising 10 percent per year and doubling over the last decade, according...
READ MOREA new meta-analysis has found that delirium, a condition developed by many patients in hospital intensive care units (ICU), is associated with higher...
READ MORECAE Healthcare announced on October 30, 2012, that it sold its 1,000th iStan patient simulator. It was sold to the Paris Simulation Center at the...
READ MORE